4.6 Review

Type III CRISPR-Cas systems: when DNA cleavage just isn't enough

Journal

CURRENT OPINION IN MICROBIOLOGY
Volume 37, Issue -, Pages 150-154

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2017.08.003

Keywords

-

Categories

Funding

  1. Rita Allen Scholars Program
  2. Burroughs Wellcome Fund PATH Award
  3. NIH Director's New Innovator Award [1DP2AI104556-01]
  4. HHMI-Simons Faculty Scholar Award

Ask authors/readers for more resources

Type III CRISPR-Cas systems have a unique targeting mechanism that requires the transcription of the DNA target and results in the degradation of not only the genome of the invader but also its transcripts. Here we discuss the most recent studies describing dual DNA and RNA targeting by these systems, as well as the implications of this complex molecular mechanism for immunity in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available